Sitemap
- 新報網站
- Boehringer Ingelheim reafirma la seguridad de telmisartan con un análisis de 50.000 pacientes y discrepa absolutamente de las conclusiones publicadas por Sipahi et al en el Lancet Oncology de junio 2010.
- Boehringer Ingelheim AB - Kommentar till publikation i Lancet - MyNewsdesk
- TUMORI BOEHRINGER INGELHEIM NESSUN LEGAME CON ANTIPERTENSIVI - Agenzia di stampa Asca
- Pine Bark Extract Helps Counteract Kidney Damage | Personal Liberty Digest
- Pycnogenol May Counteract Kidney Damage
- Timothy Hill, who was at center of ’07 Wikipedia flap, picks up papers to seek Mumpower's seat - Kingsport Times-News Online
- Erectile dysfunction helped predict cardiac events, death
- FDA urged to push hotline for side effects | Health | Reuters
- FDA warns to not eat smoked catfish steaks or other seafood from Texas seafood plant
- FDA Panel Considers Toll-Free Number for TV Drug Ads - washingtonpost.com
- The New York Times > Log In
- Discomforting compromise -- Product Recalls -- baltimoresun.com
- The New York Times > Log In
- Faustian bargain: Legislation in Congress to regulate tobacco bans all flavored cigarettes except the most popular one | Chron.com - Houston Chronicle
- Recent editorials from New Jersey newspapers -- Referenda, Arnold Schwarzenegger, New Jersey -- Newsday.com
- Dr Reddy launches “Atocor-R”, a cardiovascular drug in Indian market | Top News
- DNA - Money - Dr Reddy's launches Atocor-R in India - Daily News & Analysis
- Dr Reddy's launches "Atocor-R", a combination of Atorvastatin and Ramipril in India - EquityBulls.com
- RTTNews - Breaking News, financial breaking News, Positive EPS Surprises, Stock research ....
- Dun & Bradstreet Corp. Q1 2008 Earnings Call Transcript - Seeking Alpha
- Gartner Q1 2008 Earnings Call Transcript - Seeking Alpha
- King Pharmaceuticals, Inc. Q1 2008 Earnings Call Transcript - Seeking Alpha
- Moneycontrol India :: News :: Lupin in good health :: Lupin :: Buzzing Stocks :: Lupin
- Pharma Blog Watch
- Cobalt Drops Suit Against FDA
- Inflation still China's main economic worry -Wen | Reuters
- SemGroup Energy Partners, L.P. Acquires 2.0 Million Barrels of New Crude Oil Storage;... | Reuters
- Patent war: Lupin's US generic plan in trouble-India Business-Business-The Times of India
- Pharmacy firm to settle with states | delawareonline | The News Journal
- Kansas City infoZine News - Attorneys General Reach Settlement with Express Scripts - USA
- kwmu NewsRoom
- Prescription Drugs | Express Scripts Reaches $9.5M Settlement With 28 States Over Allegations of Misleading Consumers To Obtain Rebates - Kaisernetwork.org
- Business News for the Central Pennsylvania region including the Harrisburg, York and Lancaster areas - CentralPennBusiness.com
- Express Scripts Settles Drug Switching Charges For $9.3 Million
- KLTV 7 News Tyler, Longview, Jacksonville |Express Script Inc. To Pay States 9.3 Million, Offer Restitution For Customers
- WeAreCentralPA.com - PA to Receive Settlement Money
- Express Scripts pays $9.5M settlement over drug switching - FierceHealthcare
- KMEG 14 - News, Weather, Sports for Sioux City and Siouxland | Express Scripts to pay $9.5M in settlement with states, including SD
- News 8 Austin | 24 Hour Local News | LOCAL NEWS
- Montana's News Station - Fair. Accurate. To the Point. -Express Scripts to pay $9.5M in settlement
- Express Scripts to pay $9.3 million - 05/29/2008 - MiamiHerald.com
- Vt. to join in $9.5M Express Scripts payout: Times Argus Online
- AG Announces Mutli-State Settlement with Express scri pts Inc.
- Columbia Missourian - Express Scripts will pay Missouri $246,053
- Express Scripts In Voluntary Agreement With State AGs
- Express Scripts to pay $9.5M under settlement with state attorneys general - Forbes.com
- Express Scripts resolves state investigation | Reuters
- Express Scripts to pay $9.5M in settlement - Forbes.com
- N.C. to receive $300K from settlement - Charlotte Business Journal:
- Express Scripts enters $9.5 million agreement in drug switching probe - St. Louis Business Journal:
- Ohio awarded $410K in Rx benefits settlement - Business First of Columbus:
- Express Scripts to pay $9.5M in settlement - Forbes.com
- Express Scripts settlement includes Missouri - Kansas City Business Journal:
- Express Scripts Inc. Settles Allegations -- Medicine, Richard Blumenthal, Express Scripts Incorporated -- Courant.com
- Florida part of Express Scripts settlement - Jacksonville Business Journal:
- Tennessee included in Express Scripts settlement - Nashville Business Journal:
- Texas joins Express Scripts drug settlement - Dallas Business Journal:
- Weak medicine for an unhealthy system - Los Angeles Times
- Getting To Goal With Fixed Combinations: Tricks of the Trade
- PharmaLive: Rasilez, An Important New Treatment for High Blood Pressure, Receives Positive Opinion Recommending European Union Approval
- autoweb.cz
- NEJM -- Rosiglitazone and Cardiovascular Risk
- News: King Pharmaceuticals Joins Together Rx Access(TM) To Help Americans Without Prescription Drug Coverage. Genetic Engineering News - Biotechnology from Bench to Business
- Sick Heart - Newindpress.com
- Glaxo defends Avandia ahead of U.S. hearing| Business| Reuters
- Avandia concerns spark regulatory debate - NewsFlash - mlive.com
- FT.com / Companies / Drugs & healthcare - GSK lashes out at leading medical journal
- UPDATE: Glaxo Defends Avandia's Safety Before Congress
- Avandia concerns spark regulatory debate | Chron.com - Houston Chronicle
- Avandia Concerns Spark Regulatory Debate - Forbes.com
- Waxman accuses FDA of 'major failure' over Avandia safety - Jun. 6, 2007
- Diabetes drugs to get new warnings
- Avandia Concerns Spark Regulatory Debate, Democrats In Congress Use Avandia Controversy To Push For Tougher Restrictions On Drug Makers - CBS News
- ABC News: Avandia Concerns Spark Regulatory Debate
- Welcome to AJC! | ajc.com
- Glaxo defends Avandia ahead of hearing - Breaking News - Business - Breaking News
- Risks of Glaxo diabetes drug still unclear: FDA| Science & Health| Reuters
- Risks of Glaxo diabetes drug still unclear: FDA
- Risks of Glaxo diabetes drug still unclear: FDA: Scientific American
- F.D.A. Issues Strictest Warning on Diabetes Drugs - New York Times
- Diabetes group urges patient caution on Avandia | Reuters.com
- Avandia to carry stronger warning label
- Avandia to Carry Stronger Warning Label - Forbes.com
- Avandia to Carry Stronger Warning Label | Chron.com - Houston Chronicle
- Avandia to carry stronger warning label - NewsFlash - mlive.com
- Heart risks prompt new warnings for diabetes drugs
- The New York Times > Log In
- UPDATE: FDA Wants Black Box On Avandia, Actos Diabetes Drugs
- 3rd UPDATE: FDA Wants Black Box On Avandia, Actos Drugs
- On Avandia, a Niche Strategy Now Under Stress - New York Times
- FDA wants 'black box' warning on Glaxo drug - Triangle Business Journal:
- Sign Up
- FDA seeks warnings on 2 drugs - Newsday.com
- Diabetes drug to get 'black box' warning - Diabetes - MSNBC.com
- Drug-Maker Defends Rosiglitazone in Letter to The Lancet - CME Teaching Brief® - MedPage Today
- PharmaLive: Statement of Andrew C. Von Eschenbach, M.D. Commissioner of Food And Drugs before The Committee on Oversight and Government Reform United States House of Representatives "Avandia"
- International market boosts Dr Reddy's revenue
- More Altace News Articles...
- FDA: safety information on diabetes drug Rosiglitazone
- Statement of Moncef Slaoui, PhD, Chairman Research & Development ...
- Statement of Moncef Slaoui, PhD, Chairman Research & Development ...
- Heart Attack
- Research and Markets: Analyze Dr Reddy's - the Second Largest ...
- King Pharma Rises on Analyst Praise
- King Fights for Its Empire
- Mylan Labs in Deal to Buy German Generic Drug Unit
- King Pharmaceuticals reports 1Q earnings for 2007
- Alzheimer’s Disease - Lisinopril and Certain ACE Inhibitors Lower ...
- Some Hypertension Drugs May Help Reduce Dementia Risk
- Some hypertension drugs may help reduce dementia risk
- Centrally Active ACE Inhibitors Linked to Lower Rates of Mental ...
- Heart Attack
- Heart Attack
- Tekturna First New Type of High Blood Pressure Medicine
- Take Action to Reduce Heart Disease and Stroke
- Even 'high normal' glucose levels may increase the risk of ...
- Zacks Bull and Bear of the Day Highlights: 51job, Hewitt Associates ...
- King Pharmaceuticals CEO says 2006 'a good year'
- Some insurers raise drug prices after enrollment
- King's Altace OK'd in tablet form
- King Pharma Swings to 4Q Profit
- King Pharmaceuticals Announces FDA Approval of ALTACE(R) Tablet ...
- Niacin a possible alternative to Lipitor
- FDA's ruling on quinine use upsets a leg-cramp sufferer
- Beta-Blockers Should Not Be First Choice For High Blood Pressure
- UPI NewsTrack Health and Science News
- Study: Beta-blocker drugs have higher risk
- Study: Beta-blocker drugs have higher risk
- UPI NewsTrack Health and Science News
- Beta-Blockers Should Not Be First Choice for High Blood Pressure
- Beta-Blockers Should Not Be First Choice for High Blood Pressure
- Sanofi-aventis 2006: In a Difficult Environment, Another Year of...
- TV Spot Aims for the Heart of the Super Bowl's Couch Potatoes
- TV Spot Aims for the Heart of the Super Bowl's Couch Potatoes
- Sanofi-aventis 2006: In a Difficult Environment, Another Year of ...
- Super Bowl ads: K-Fed, Jay-Z, Robert Goulet?
- American Heart Association: Beat Your Risk quiz
- Drug battle could knock King from its throne
- Drug battle could knock King from its throne
- Super Bowl skips product mention
- No Mention Of Brand In King Pharma's Super Bowl Ad
- Super Bowl ad doesn't mention product
- BUSINESS NEWS
- Super Bowl Ad Warns of Heart Attack Risks
- I am Over Weight and Smoking after Heart Attack but want to Stop my ...
- Quinine is overkill for leg cramps
- I am Over Weight and Smoking after Heart Attack but want to Stop my ...
- I am Over Weight and Smoking after Heart Attack but want to Stop my ...
- Journal Watch
- Classes of Medications
- Attention Assignment Editors/Health Editors:
- NEJM AUDIO SUMMARY
- To Dream ... Perchance To Prevent Diabetes
- Diabetes Drug Might Prevent the Disease
- Preventing Cardiovascular Disease in Women
- Ramipril of Limited Benefit in Preventing Diabetes
- Diabetes Drug Might Prevent the Disease
- NEJM AUDIO SUMMARY
- Firstcoastnews.com Article
- Definition of Coronary Artery Heart Disease
- Diabetes Drug Might Prevent the Disease
- BIO InvestorForum Therapeutic Workshops Draw Experts to Discuss ...
- David vs Goliath: Taming the Diabetes Epidemic
- Diabetes pill works — but at what cost?
- Drug slows beginning of diabetes, study shows
- Fluid-filled sac on elbow is a bursa swollen from injury
- Study: Diabetes Drug Also May Prevent It
- Reviews mixed on GSK`s DREAM
- Drug stalls onset of diabetes
- TRANSLATIONAL MEDICINEChannel Diabetes/Obesity News
- Schering-Plough Eyes Bristol-Myers Deal and GSK Drug Effective in ...
- Welcome, Barbarians! How to profit from the buyout craze
- Potential cure, prevention for diabetes found
- Diabetes drug also helps prevent disease
- Potential cure, prevention for diabetes found
- Drug can help prevent diabetes, study says
- Diabetes Drug Might Prevent the Disease
- Drug used to treat diabetes might also prevent the disease
- Diabetes drug offers preventive hope
- Drug might alter diabetes’ progress
- Drug may slow development of diabetes
- Drug May Delay or Even Prevent Type 2 Diabetes
- Avandia(R) (rosiglitazone Maleate) Reduced Risk Of Progression From ...
- ? Diabetes drug can prevent the disease
- Early treatment with drugs cuts risk, study says
- Diabetes Drug Might Prevent the Disease
- Drug May Delay or Even Prevent Type 2 Diabetes
- Avandia a diabetes DREAM?
- Midday Business Report: Inflation pushes real earnings down in August
- Drug helps prevent diabetes in those at high risk, study finds; diet ...
- King Pharma Reports Results Of DREAM Study - Update
- Online Press Release
- Generic competition akin to death sentence for branded prescription ...
- King announces launch of new treatment for type 2 diabetes
- Definition of Coronary Artery Heart Disease
- Early Alcoholism Harder to Overcome
- BP Lowering Effects of Aliskiren Are Additive to Amlodipine, Persist ...
- GlaxoSmithKline Up on Analyst Comment
- More Altace Newsfeeds...





